DPP4 and Hyperglycemia: Several new classes of medications have been developed for the treatment of hyperglycemia, including glucagon-like peptide I (GLP-I) analogs, sodium-glucose co-transporter 2 (SGLT-2) inhibitors, and dipeptidyl peptidase 4 (DPP-4) inhibitors [9].